MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Clinical Significance of Imaging Markers for Cerebellar Ataxia and Parkinsonism in Multiple System Atrophy

Y. Nakano, A. Sugiyama, Y. Nakagawa, M. Tamura, Y. Koizumi, Y. Suzuki, K. Yamagishi, Y. Chishiki, K. Osawa, T. Yamamoto, Y. Yamanaka, M. Mori, S. Hirano (Chiba, Japan)

Meeting: 2026 International Congress

Keywords: Multiple system atrophy(MSA): Clinical features, Multiple system atrophy(MSA): Pathophysiology, Single-photon emission computed tomography(SPECT)

Category: MSA, PSP, CBS: Neuroimaging

Objective: To clarify the interactions among clinical features and imaging markers, and to identify factors contributing to disease severity in MSA.

Background: Multiple system atrophy (MSA) presents with cerebellar ataxia, Parkinsonism, and autonomic dysfunction, but relationships among these degenerative systems remain unclear. Recent clinical trials often use the Unified Multiple System Atrophy Rating Scale (UMSARS) total score as a primary outcome. However, established biological markers reflecting clinical progression are lacking. We previously developed perfusion patterns estimating cerebellar ataxia and Parkinsonian severity in MSA, termed MSA-AP (ataxia-related pattern) and MSA-PP (parkinsonism-related pattern).

Method: A total of 122 patients with MSA were randomly divided into a training cohort (n=70) and a validation cohort (n=52). Principal component analysis of brain perfusion SPECT (123I-IMP) images in the training cohort identified MSA-AP and MSA-PP associated with International Cooperative Ataxia Rating Scale (ICARS) and Unified Parkinson’s Disease Rating Scale part III (UPDRS-III). Individual pattern expressions were calculated in the validation cohort. Clinical variables associated with the UMSARS total score were selected by partial least squares regression. Structural equation modeling (SEM) was applied to evaluate relationships among imaging pattern expression (MSA-AP and MSA-PP), clinical variables, and disease severity.

Results: Age, disease duration, ICARS, UPDRS-III, overactive bladder symptom score (OABSS), postvoid residual urine (PVR), and Addenbrooke’s Cognitive Examination-III (ACE-III) were associated with UMSARS total score and were included in the SEM analysis together with MSA-AP and MSA-PP. The best-fitting model (CFI=0.96) showed that longer disease duration increased ICARS scores, whereas older age increased OABSS and MSA-PP. Increased OABSS was associated with reduced MSA-PP and higher UPDRS-III scores. Lower ACE-III scores contributed to higher UMSARS scores through increased ICARS. ICARS, UPDRS-III, and PVR showed direct associations with UMSARS total score.

Conclusion: Imaging patterns reflecting cerebellar and Parkinsonian motor systems (MSA-AP and MSA-PP) were integrated with autonomic and cognitive factors in determining disease severity. SEM revealed interactions among these domains, suggesting a framework for the multidomain progression of MSA.

To cite this abstract in AMA style:

Y. Nakano, A. Sugiyama, Y. Nakagawa, M. Tamura, Y. Koizumi, Y. Suzuki, K. Yamagishi, Y. Chishiki, K. Osawa, T. Yamamoto, Y. Yamanaka, M. Mori, S. Hirano. Clinical Significance of Imaging Markers for Cerebellar Ataxia and Parkinsonism in Multiple System Atrophy [abstract]. Mov Disord. 2026; 41 (suppl 1). https://www.mdsabstracts.org/abstract/clinical-significance-of-imaging-markers-for-cerebellar-ataxia-and-parkinsonism-in-multiple-system-atrophy/. Accessed October 1, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/clinical-significance-of-imaging-markers-for-cerebellar-ataxia-and-parkinsonism-in-multiple-system-atrophy/

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley